GHC RES DEV CORP has a total of 22 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are NAT JEWISH MED & RES CENTER, IST SUPERIORE SANITA and ZOETIS BELGIUM S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | China | 1 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Measurement | |
#5 | Agriculture | |
#6 | Foods and drinks | |
#7 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Unspecified technologies | |
#6 | Animal care | |
#7 | Analysing materials | |
#8 | Enzymes | |
#9 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Wagner Thomas E | 14 |
#2 | Wei Yanzhang | 7 |
#3 | Yu Xianzhong | 6 |
#4 | Chen Wen Yuan | 5 |
#5 | Schwamberger Gunter | 2 |
#6 | Park Jang P | 2 |
#7 | Wagner Thomas | 2 |
#8 | Xianzhong Yu | 1 |
#9 | Chen Wen Yuang | 1 |
#10 | Montgomery Mitzi M | 1 |
Publication | Filing date | Title |
---|---|---|
WO2009094387A1 | Compositions and methods for inducing tumor resistance | |
WO2009032364A1 | Activation of nuclear factor-kappa b | |
CA2626785A1 | Use of prolactin in the prophylactic treatment of cancer | |
US2006264364A1 | Acetylated therapeutic procytotoxins | |
EP1696949A2 | Vegf receptor antagonists | |
US7456146B2 | Lytic peptide prodrugs | |
EP1908475A1 | Use of anti-prolactin agents to treat cancer |